Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH · NASDAQ · Financial Services / Asset Management

1.87USD-0.07 (-3.86%)

Price History

Full chart

Market Stats

Previous Close1.95
Open2.00
Day Range1.85 – 2.03
52-Week Range0.33 – 4.19
Volume13.38M
Market Cap439.68M
P/E (TTM)5.67
Forward P/E0.00
EPS0.72
Dividend Yield0.00%
Beta0.33
50-Day Avg1.53
200-Day Avg1.04

About

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. Cypherpunk Technologies Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Company Details

  • SectorFinancial Services
  • IndustryAsset Management
  • CEOMr. Douglas E. Onsi J.D.
  • Employees6
  • Headquarters47 Thorndike Street, Cambridge, MA, United States, 02141, USA
  • Websitehttps://www.cypherpunk.com

Leadership

  • Mr. Douglas E. Onsi J.D.CFO, General Counsel, Treasurer & Secretary, President, CEO & Director · b. 1969
  • Mr. Will McEvoyChief Investment Officer & Director · b. 1996
  • Kevin ZhangHead of Mining

Financials

Income Statement

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-------9.68M10.05M1.50M0000
Growth (%)--------+3.85%-85.08%-100.00%---
Cost of Revenue----25.00K48.00K49.00K4.56M4.93M--427.00K--
Gross Profit-----25.00K-48.00K-49.00K5.12M5.12M1.50M--427.00K--
Gross Margin-------52.93%50.94%100.00%----
Operating Expense----27.50M32.30M30.70M8.60M8.57M42.93M-86.61M--
Operating Income-8.80M-13.87M-20.92M-21.09M-27.52M-32.35M-30.75M-3.48M-3.45M-41.43M-56.76M-87.04M-70.06M-36.54M
Operating Margin--------35.91%-34.28%-2761.73%----
EBITDA-6.98M-13.23M-19.73M-11.92M-24.37M-29.71M-23.05M-3.27M-3.23M-40.54M-54.38M-80.99M-66.97M-36.54M
EBITDA Margin--------33.78%-32.10%-2702.73%----
Net Income-7.76M-18.32M-25.45M-21.10M-25.63M-29.73M-23.14M-3.45M-3.39M-40.59M-54.60M-81.41M-67.56M4.82M
Net Income Margin--------35.60%-33.69%-2705.80%----
R&D7.17M9.30M15.54M15.37M23.29M22.50M21.07M1.13M1.43M32.16M44.97M73.23M57.21M25.67M
R&D as % of Total Revenue-------11.63%14.19%2144.00%----
Interest Expense--4.37M18.00K1.23M121.00K19.00K23.00K39.00K41.00K54.00K0024.00K
Interest Expense % of Total Revenue-------0.24%0.39%2.73%----

Balance Sheet

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets17.71M20.74M48.70M28.15M6.46M29.06M19.07M8.70M70.42M117.91M58.09M72.83M49.12M163.18M
Total Liabilities4.61M1.97M2.49M1.28M6.46M17.95M9.90M2.98M3.01M10.02M3.45M12.68M14.08M9.68M
Total Equity13.10M18.77M46.21M26.87M-100.23M11.12M9.18M5.72M67.41M107.89M54.64M60.14M35.05M153.51M
Cash15.32M19.00M10.87M20.97M793.00K25.74M16.28M2.39M63.83M114.92M20.99M70.64M47.25M14.04M
Total Debt---3.14M30.27M--1.00M776.00K469.00K524.00K262.00K266.00K38.00K
Net Debt-15.32M-19.00M-10.87M-17.83M29.48M-25.74M-16.28M-1.39M-63.05M-114.45M-20.47M-70.38M-46.98M-14.00M

Cash Flow

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-7.55M-9.94M-18.02M-19.58M-25.34M-22.14M-26.03M-26.90M-25.96M-35.16M-49.04M-43.75M-60.30M-43.90M
Investing Cash Flow-136.00K-114.00K-36.80M29.69M-144.00K-64.00K--85.00K25.00K--48.97M--97.00M
Financing Cash Flow12.29M13.75M46.89M16.00K25.62M47.76M15.91M14.82M74.00M98.03M-210.00K-30.00K37.18M107.65M
Capital Expenditure130.00K116.00K227.00K12.00K144.00K64.00K0100.00K0000097.00M
Free Cash Flow-7.68M-10.05M-18.24M-19.59M-25.48M-22.20M-26.03M-27.00M-25.96M-35.16M-49.04M-43.75M-60.30M-43.90M
FCF to OCF101.72%101.17%101.26%100.06%100.57%100.29%100.00%100.37%100.00%100.00%100.00%100.00%100.00%100.00%

Earnings

Report DateMay 12, 2017Aug 11, 2017Nov 13, 2017Feb 23, 2018May 11, 2018Aug 8, 2018Nov 9, 2018May 15, 2019Aug 9, 2019Nov 14, 2019Mar 16, 2020May 14, 2020Aug 13, 2020Nov 12, 2020Mar 12, 2021May 14, 2021Aug 13, 2021Nov 12, 2021Mar 11, 2022May 13, 2022Aug 12, 2022Nov 14, 2022Mar 24, 2023May 15, 2023Aug 14, 2023Nov 13, 2023Mar 18, 2024May 13, 2024Aug 12, 2024Nov 13, 2024Mar 26, 2025May 13, 2025Aug 14, 2025Nov 12, 2025Mar 16, 2026May 14, 2026Aug 12, 2026Nov 11, 2026
EPS Estimate-8.65-7.10-6.15--6.10-4.90-4.33-4.10-4.25-3.30--3.80-1.93-1.23-0.09-1.10-1.30-1.18-0.11-1.00-0.97-1.17-1.05-0.09-0.88-0.58--0.59-0.40-0.47-0.36-0.40-0.29-0.24--0.12-0.03-0.02
EPS Actual-13.90-7.40-7.30-6.48-8.50-5.00-4.50-4.70-3.70-3.30-3.30-5.50-1.20-0.90-0.09-1.20-1.20-1.40-0.10-0.90-1.50-1.30-1.00-0.32-0.91-0.51-0.46-0.51-0.52-0.44-0.37-0.37-0.40-0.080.92-0.46-0.03-
Surprise-60.69%-4.23%-18.70%--39.34%-2.04%-3.93%-14.63%12.94%0.00%--44.74%37.82%26.83%-2.27%-9.09%7.69%-18.64%9.09%10.00%-54.64%-11.11%4.76%-272.09%-3.41%12.07%-13.56%-30.00%6.38%-2.78%7.50%-37.93%66.67%--283.33%0.00%-
TimingPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap439.68M
Enterprise Value381.44M
Trailing P/E5.67
Forward P/E0.00
Price / Sales160.10
Price / Book2.79
EPS0.72
Book Value1.29
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-36.69M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-1.21%
Return on Assets-13.79%
Shares Outstanding107.76M
Shares Float74.75M
Beta0.33
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
37.26%
Insiders
8.63%
Retail / Other
54.11%

Top Institutional Holders

  • BlackRock Inc
    2.34M2.17%
  • Vanguard Capital Management, LLC
    1.82M1.69%
  • Citadel Advisors Llc
    836.15K0.78%
  • Renaissance Technologies Corp
    725.12K0.67%
  • Geode Capital Management, LLC
    571.07K0.53%
  • Vanguard Fiduciary Trust Co
    297.09K0.28%
  • Susquehanna International Group, LLP
    262.95K0.24%
  • UBS Group AG
    171.07K0.16%
  • LPL Financial Corp
    162.49K0.15%
  • Sequoia Financial Advisors LLC
    152.50K0.14%
  • State Street Corp
    140.11K0.13%
  • Group One Trading, LLC
    107.42K0.10%
  • Northern Trust Corp
    87.56K0.08%
  • Two Sigma Investments LLC
    80.41K0.07%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    2.63M2.44%
  • BIT Global Crypto Leaders I-I
    1.21M1.12%
  • Fidelity Extended Market Index
    494.36K0.46%
  • Fidelity Total Market Index
    170.45K0.16%
  • Fidelity Series Total Market Index
    141.49K0.13%
  • Datamira LS World Fund F EUR Acc
    100.00K0.09%

Stock Splits

  • Jun 21, 20231:10